APO-METHYLPHENIDATE
APOTEX INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of APO-METHYLPHENIDATE in Canada?
Yes. APO-METHYLPHENIDATE 5MG has an active shortage reported to Health Canada (last updated October 30, 2026).
Why is APO-METHYLPHENIDATE not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will APO-METHYLPHENIDATE be available again?
The manufacturer's estimated resolution date is November 13, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
ADHD Medication Shortage in Canada: What to Know
Why ADHD medications go into shortage in Canada more often than most drug classes, which ones are most affected, and what to do if yours is short-supplied.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Other Products
QUILLIVANT ER ORAL SUSPENSION
Extended-ReleaseKYE PHARMACEUTICALS INC.
PMS-METHYLPHENIDATE
PHARMASCIENCE INC
APO-METHYLPHENIDATE
APOTEX INC
AA-METHYLPHENIDATE SR
Extended-ReleaseAA PHARMA INC
CONCERTA
JANSSEN INC
APO-METHYLPHENIDATE ER
Extended-ReleaseAPOTEX INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02273950
Strength
5MG
Dosage Form
TABLET
Route
ORAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554178
2MG · DIN 02554194